GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Pozycja w akcjach
#3644
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Cena akcji
$27.54
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$4.67B
Zmiana (1 dzień)
-2.73%
Zmiana (1 rok)
-12.13%
Kraj
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategoria
Healthcare
Wskaźnik P/B dla GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Wskaźnik P/B na dzień October 2026 TTM: 18.70
Według najnowszych raportów finansowych i ceny akcji GlaxoSmithKline Pharmaceuticals Limited, obecny wskaźnik P/B (TTM) wynosi 18.70. Na koniec 2024 wynosił 18.93.
Historia wskaźnika P/B dla GlaxoSmithKline Pharmaceuticals Limited od 2004 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 18.70 | -23.00% |
| 2025 | 24.29 | 28.30% |
| 2024 | 18.93 | 46.87% |
| 2023 | 12.89 | 21.54% |
| 2022 | 10.60 | -35.77% |
| 2021 | 16.51 | 41.12% |
| 2020 | 11.70 | 13.72% |
| 2019 | 10.29 | 18.79% |
| 2018 | 8.66 | -25.23% |
| 2017 | 11.58 | -39.20% |
| 2016 | 19.05 | 60.47% |
| 2015 | 11.87 | -7.01% |
| 2013 | 12.77 | 39.51% |
| 2012 | 9.15 | 7.51% |
| 2011 | 8.51 | -16.10% |
| 2010 | 10.15 | 32.71% |
| 2009 | 7.64 | 23.58% |
| 2008 | 6.19 | -1.82% |
| 2007 | 6.30 | -22.76% |
| 2006 | 8.16 | -19.22% |
| 2005 | 10.10 | 38.74% |
| 2004 | 7.28 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| 31.9092 | 70.60% |
US
|
|
| 7.3138 | -60.90% |
US
|
|
| -84.6033 | -552.32% |
US
|
|
| 8.6873 | -53.56% |
US
|
|
| 8.4776 | -54.68% |
CH
|
